O Andersson

1.1k total citations
26 papers, 875 citations indexed

About

O Andersson is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, O Andersson has authored 26 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 7 papers in Physiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in O Andersson's work include Blood Pressure and Hypertension Studies (9 papers), Heart Rate Variability and Autonomic Control (6 papers) and Diet and metabolism studies (6 papers). O Andersson is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Heart Rate Variability and Autonomic Control (6 papers) and Diet and metabolism studies (6 papers). O Andersson collaborates with scholars based in Sweden, United States and Austria. O Andersson's co-authors include Thomas Hedner, G Berglund, Björn Fagerberg, Bertil Persson, Ola Samuelsson, Lars Wilhelmsen, Per Björntorp, B Isaksson, Jan M. Lundberg and B. Gunnar Wallin and has published in prestigious journals such as Hypertension, American Journal of Physiology-Endocrinology and Metabolism and British Journal of Clinical Pharmacology.

In The Last Decade

O Andersson

26 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Andersson Sweden 17 562 219 194 132 116 26 875
Ove K. Andersson Sweden 18 570 1.0× 164 0.7× 252 1.3× 103 0.8× 92 0.8× 56 890
Thorkell Gudbrandsson United States 14 664 1.2× 227 1.0× 285 1.5× 88 0.7× 47 0.4× 27 1.0k
Ivar K. Eide Norway 14 456 0.8× 120 0.5× 269 1.4× 163 1.2× 60 0.5× 27 789
Osvaldo Kohlmann Brazil 17 522 0.9× 112 0.5× 214 1.1× 69 0.5× 93 0.8× 58 981
K Stepniakowski United States 17 416 0.7× 324 1.5× 315 1.6× 129 1.0× 55 0.5× 30 1.1k
Paola Lusardi Italy 17 663 1.2× 247 1.1× 305 1.6× 78 0.6× 96 0.8× 44 1.3k
Haskel Eliahou Israel 9 228 0.4× 269 1.2× 165 0.9× 114 0.9× 158 1.4× 15 795
J.F. Potter United Kingdom 18 579 1.0× 163 0.7× 99 0.5× 101 0.8× 72 0.6× 43 1.2k
Iwao Kuwajima Japan 18 1.1k 1.9× 91 0.4× 148 0.8× 133 1.0× 57 0.5× 80 1.3k
Laura I. Rankin United States 13 306 0.5× 215 1.0× 130 0.7× 392 3.0× 137 1.2× 22 1.2k

Countries citing papers authored by O Andersson

Since Specialization
Citations

This map shows the geographic impact of O Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Andersson more than expected).

Fields of papers citing papers by O Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Andersson. The network helps show where O Andersson may publish in the future.

Co-authorship network of co-authors of O Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of O Andersson. A scholar is included among the top collaborators of O Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Andersson. O Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Andersson, O, et al.. (1998). Survival in treated hypertension: follow up study after two decades. BMJ. 317(7152). 167–171. 147 indexed citations
3.
Samuelsson, Ola, Kjell Pennert, O Andersson, et al.. (1996). Diabetes mellitus and raised serum triglyceride concentration in treated hypertension—are they of prognostic importance? Observational study. BMJ. 313(7058). 660–663. 33 indexed citations
4.
Müller, Manfred J., Agneta Holmäng, O Andersson, Hans Georg Eichler, & Peter Lönnroth. (1996). Measurement of interstitial muscle glucose and lactate concentrations during an oral glucose tolerance test. American Journal of Physiology-Endocrinology and Metabolism. 271(6). E1003–E1007. 31 indexed citations
5.
Samuelsson, Ola, Thomas Hedner, G Berglund, et al.. (1994). Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden.. PubMed. 8(4). 257–63. 55 indexed citations
6.
Widgren, Bengt R., John Wikstrand, G Berglund, & O Andersson. (1992). Increased response to physical and mental stress in men with hypertensive parents.. Hypertension. 20(5). 606–611. 43 indexed citations
7.
Andersson, O, et al.. (1991). Metabolic adverse effects of thiazide diuretics: the importance of normokalaemia.. PubMed. 735. 89–96. 27 indexed citations
8.
Berglund, Agnethe, O Andersson, G Berglund, & Björn Fagerberg. (1989). Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension.. BMJ. 299(6697). 480–485. 25 indexed citations
9.
Eckberg, Dwain L., Robert F. Rea, O Andersson, et al.. (1988). Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans. Acta Physiologica Scandinavica. 133(2). 221–231. 143 indexed citations
10.
Hedner, T., O Andersson, A. Pettersson, & Bertil Persson. (1987). Cardiovascular Effects of Ketanserin During Cold Pressure and During Isometric and Dynamic Exercise in Hypertensive Patients. Journal of Cardiovascular Pharmacology. 10. S73–S77. 3 indexed citations
11.
Dubois, J.P., et al.. (1987). Metabolism of hydralazine in man. Part II: Investigation of features relevant to drug safety.. PubMed. 37(2). 189–93. 2 indexed citations
12.
Hedner, Thomas, O Andersson, A. Pettersson, & Bertil Persson. (1987). Cardiovascular effects of ketanserin during cold pressure and during isometric and dynamic exercise in hypertensive patients.. PubMed. 10 Suppl 3. S73–7. 3 indexed citations
13.
Andersson, O, Thomas Hedner, & G. Nyberg. (1986). Acute and Long-Term Antihypertensive Effect of Bopindolol Once Daily or Once Weekly. Journal of Cardiovascular Pharmacology. 8(Supplement 6). S74–S76. 5 indexed citations
14.
Andersson, O, Thomas Hedner, & G. Nyberg. (1985). Acute and long-term antihypertensive effect of bopindolol ? A nonselective ?-adrenergic blocker with ISA. European Journal of Clinical Pharmacology. 29(3). 281–285. 7 indexed citations
15.
Fagerberg, Björn, O Andersson, Bertil Persson, & Thomas Hedner. (1985). Reactivity to norepinephrine and effect of sodium on blood pressure during weight loss.. Hypertension. 7(4). 586–592. 16 indexed citations
16.
Fagerberg, Björn, O Andersson, B Isaksson, & Per Björntorp. (1984). Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction.. BMJ. 288(6410). 11–14. 99 indexed citations
17.
Dahlöf, Björn, O Andersson, Thomas Thulin, et al.. (1984). Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1‐adrenoceptor blocker with ISA‐a multicentre trial in 59 patients.. British Journal of Clinical Pharmacology. 18(6). 831–836. 10 indexed citations
18.
Berglund, G, et al.. (1983). Influence of age on the response to increased salt intake: effects on blood pressure and sodium in erythrocytes.. PubMed. 1(2). 15–7. 7 indexed citations
19.
Berglund, G & O Andersson. (1981). Body composition, metabolic and hormonal characteristics in unselected male hypertensives.. PubMed. 5 suppl 1. 143–50. 20 indexed citations
20.
Andersson, O, G Berglund, Hanna Bergman, et al.. (1975). [Antihypertensive effect and adverse effects of treatment with beta-blocking agents].. PubMed. 72(48). 4738–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ove K. Andersson Breakdown of academic impact, for papers by Thorkell Gudbrandsson Breakdown of academic impact, for papers by Ivar K. Eide Breakdown of academic impact, for papers by Osvaldo Kohlmann Breakdown of academic impact, for papers by K Stepniakowski Breakdown of academic impact, for papers by Paola Lusardi Breakdown of academic impact, for papers by Haskel Eliahou Breakdown of academic impact, for papers by J.F. Potter Breakdown of academic impact, for papers by Iwao Kuwajima Breakdown of academic impact, for papers by Laura I. Rankin
Rankless by CCL
2026